Clinical Trials Logo

Clinical Trial Summary

SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.


Clinical Trial Description

Patients are recruited in the platform for the research purpose of 4 downstream projects. For more information, please have a look at the "Groups and cohorts" section. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02834884
Study type Observational [Patient Registry]
Source European Organisation for Research and Treatment of Cancer - EORTC
Contact EORTC HQ
Phone +32 2 774 1611
Email specta@eortc.org
Status Recruiting
Phase
Start date May 3, 2017
Completion date March 2026